Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Skin Cancer01:30

Skin Cancer

Skin cancer is a type of cancer that occurs when there is an abnormal growth of skin cells, usually triggered by damage to the DNA within the skin cells. It is primarily caused by exposure to ultraviolet (UV) radiation from the sun or artificial sources like tanning beds. Skin cancer is the most common type of cancer worldwide, and its incidence continues to rise.
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Biomimetic Symbiotic Engineering: Mycelial Bioceramics to Activate Energy Metabolism for Enhanced Osteogenesis.

Advanced materials (Deerfield Beach, Fla.)·2026
Same author

SiO<sub>2</sub>-based inorganic nanofiber aerogel with rapid hemostasis and liver wound healing functions.

Acta biomaterialia·2025
Same author

An injectable hyaluronic acid/lithium calcium silicate soft tissue filler with vascularization and collagen regeneration.

Bioactive materials·2024
Same author

Bioprinting of inorganic-biomaterial/neural-stem-cell constructs for multiple tissue regeneration and functional recovery.

National science review·2024
Same author

Mesoporous Bioactive Glass-Graphene Oxide Composite Aerogel with Effective Hemostatic and Antibacterial Activities.

ACS applied bio materials·2024
Same author

Cytoglobin regulates NO-dependent cilia motility and organ laterality during development.

Nature communications·2023

Related Experiment Video

Updated: Jul 10, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Malignant blue nevus with lymph node metastases.

Jill Zyrek-Betts1, Mark Micale, Angela Lineen

  • 1Department of Pathology, The University of Toledo Medical Center, Toledo, OH, USA.

Journal of Cutaneous Pathology
|November 3, 2007
PubMed
Summary

This study details a rare metastatic malignant blue nevus case. Findings suggest a potential role for hOGG-1 DNA repair gene mutation and CD117 (c-kit) upregulation in its pathogenesis.

More Related Videos

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Related Experiment Videos

Last Updated: Jul 10, 2026

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy
07:51

The Application of 1% Methylene Blue Dye As a Single Technique in Breast Cancer Sentinel Node Biopsy

Published on: June 1, 2019

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts
07:50

Utilization of Ultrasound Guided Tissue-directed Cellular Implantation for the Establishment of Biologically Relevant Metastatic Tumor Xenografts

Published on: May 25, 2018

Zebrafish Model of Neuroblastoma Metastasis
05:20

Zebrafish Model of Neuroblastoma Metastasis

Published on: March 14, 2021

Area of Science:

  • Dermatopathology
  • Oncology
  • Molecular Genetics

Background:

  • Malignant blue nevi are rare melanomas arising from cellular blue nevi.
  • They are characterized by atypical mitoses, necrosis, and nuclear pleomorphism.
  • Malignant blue nevus is sometimes misdiagnosed as melanoma.

Observation:

  • A patient with metastatic malignant blue nevus was studied.
  • Histopathology revealed a malignant blue nevus within a combined intradermal and cellular blue nevus.
  • Immunohistochemical and molecular analyses were performed on the neoplasm and metastases.

Findings:

  • The malignant blue nevus exhibited mutation of the hOGG-1 DNA repair gene.
  • CD117 (c-kit) staining showed decreased expression in the primary tumor but upregulation in lymph node metastases.
  • Loss of heterozygosity analysis at the hOGG-1 locus revealed distinct allelic patterns between the melanoma and control specimens.

Implications:

  • This case highlights the hOGG-1 DNA repair gene mutation in malignant blue nevus with metastasis.
  • CD117 (c-kit) upregulation in metastases differs from typical metastatic melanomas.
  • Further research is needed to clarify the roles of hOGG-1 mutation and c-kit upregulation in melanocytic lesions.